The paediatric response to the SARS-COV-2 virus and what we can learn from it

Saved in:
Bibliographic Details
Other Authors: Permar, Sallie (Speaker)
Format: Electronic Audio
Language:English
Published: London : Henry Stewart Talks, 2020.
Series:Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
Subjects:
Online Access:https://hstalks.com/bs/4224/
Series
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nim a2200000 a 4500
001 HST8150
003 UkLoHST
006 m o h
007 cr nna||||||||
007 sr |mnnnnnzne|
008 200404s2020 enk|||||o||h||||||||eng d
028 5 0 |a 8150  |b Henry Stewart Talks 
035 |a (UkLoHST)4224 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Permar, Sallie,  |u (Duke University Medical School, USA)  |4 spk  |9 90483 
245 1 4 |a The paediatric response to the SARS-COV-2 virus and what we can learn from it  |h [electronic resource] /  |c Sallie Permar. 
260 |a London :  |b Henry Stewart Talks,  |c 2020. 
300 |a 1 online resource (1 streaming audio file (16 min.)). 
490 1 |a Interviews on Covid-19,  |x 2056-452X 
500 |a Audio interview. 
500 |a Title from title frames. 
505 0 |a Contents: Current hypotheses on why children are less effected by COVID-19 than older individuals -- How this knowledge might benefit the treatment of older individuals -- Safety during related research -- The implications of this knowledge on vaccine development -- Future considerations for vaccine development. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Children  |x Diseases.  |9 90484 
650 0 |a Coronavirus infections  |x Immunological aspects.  |9 90485 
650 0 |a Coronaviruses.  |9 90486 
650 0 |a COVID-19 (Disease)  |9 90487 
650 0 |a Immunity.  |9 90488 
650 0 |a Older people  |x Diseases.  |9 90489 
650 0 |a Vaccines  |x Development.  |9 90490 
650 2 |a Age Factors.  |9 90491 
650 2 |a Betacoronavirus.  |9 90492 
650 2 |a Child.  |9 90493 
650 2 |a Coronavirus Infections.  |9 90494 
650 2 |a COVID-19 Vaccines.  |9 90495 
650 2 |a COVID-19  |x drug therapy.  |9 90496 
650 2 |a COVID-19  |x immunology.  |9 90497 
650 2 |a Disease Susceptibility.  |9 90498 
650 2 |a Drug Development.  |9 90499 
650 2 |a Patient Safety.  |9 90500 
650 2 |a SARS-CoV-2.  |9 90501 
650 2 |a Vaccination.  |9 90502 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Interviews on Covid-19.  |9 90503 
856 4 0 |u https://hstalks.com/bs/4224/ 
856 4 2 |u https://hstalks.com/bs/p/1060/  |3 Series 
999 |c 214117  |d 214116